Ifp Advisors, Inc Satsuma Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

  • $2.42 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021
SELL
$4.54 - $7.17 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021
BUY
$4.8 - $7.25 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021
BUY
$4.57 - $7.18 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021
BUY
$3.56 - $5.09 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020
BUY
$3.85 - $28.47 $0 - $0
0 New
0 $0

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email